Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel
Clinical trial NCT04471675 · UNKNOWN
Trial details
- NCT number
- NCT04471675
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2022-12-15
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.